ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

VTVT vTv Therapeutics Inc

19.06
0.28 (1.49%)
2024年6月21日 - 終了
15分遅延
名称 銘柄コード 市場 種別
vTv Therapeutics Inc VTVT NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.28 1.49% 19.06 06:30:00
始値 安値 高値 終値 前日終値
18.74 18.22 20.13 19.06 18.78
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/6/1505:22EDGAR2Form 8-K - Current report
2024/6/1405:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/1405:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/2821:00PRNUSCANTEX PHARMACEUTICALS ANNOUNCES FOUR ABSTRACTS TO BE..
2024/5/1005:51GLOBEvTv Therapeutics Announces 2024 First Quarter Financial..
2024/5/1005:32EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/1005:28EDGAR2Form 8-K - Current report
2024/3/1921:30PRNUSCANTEX PHARMACEUTICALS TO PRESENT AT 5TH ANNUAL GLIOBLASTOMA..
2024/3/1321:00GLOBEvTv Therapeutics Announces 2023 Fourth Quarter and Full Year..
2024/3/0806:47EDGAR2Form 3 - Initial statement of beneficial ownership of..
2024/3/0609:52EDGAR2Form SC 13D - General statement of acquisition of beneficial..
2024/3/0522:04EDGAR2Form 8-K - Current report
2024/3/0422:00GLOBEvTv Therapeutics Announces FDA Submission for First Phase 3..
2024/3/0122:00GLOBEvTv Therapeutics to Participate at the TD Cowen 44th Annual..
2024/2/2823:26EDGAR2Form 8-K - Current report
2024/2/2823:14EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/2/2822:08EDGAR2Form 8-K - Current report
2024/2/2822:00GLOBEvTv Therapeutics Announces $51 Million Private Placement..
2024/2/2306:00PRNUSCANTEX PHARMACEUTICALS TO PARTICIPATE IN THE BIO CEO &..
2023/12/2306:26EDGAR2Form 8-K - Current report
2023/12/2006:28EDGAR2Form 8-K - Current report
2023/12/1306:21EDGAR2Form 8-K - Current report
2023/11/2106:23EDGAR2Form 8-K - Current report
2023/11/1522:22EDGAR2Form 8-K - Current report
2023/11/1522:19EDGAR2Form 8-K - Current report
2023/11/1006:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/1006:30GLOBEvTv Therapeutics Announces 2023 Third Quarter Financial..
2023/11/1006:20EDGAR2Form 8-K - Current report
2023/11/0822:00GLOBEvTv Therapeutics to Participate at the Stifel 2023..
2023/11/0221:00GLOBEvTv Therapeutics Appoints Thomas Strack, M.D., as Chief..
2023/11/0121:24EDGAR2Form 8-K - Current report
2023/11/0121:00GLOBEvTv Therapeutics Announces Sale of Shares in Reneo..
2023/9/2721:30PRNUSCANTEX AND MICHIGAN MEDICINE ANNOUNCE INITIATION OF A..
2023/9/2621:30PRNUSCantex and Allegheny Health Network Announce Initiation of a..
2023/9/2605:20EDGAR2Form DEF 14C - Other definitive information statements
2023/9/1821:30PRNUSCANTEX PHARMACEUTICALS AND LENOX HILL HOSPITAL ANNOUNCE..
2023/9/1605:17EDGAR2Form PRE 14C - Other preliminary information statements
2023/8/1205:40EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1205:36EDGAR2Form 8-K - Current report
2023/8/1205:30GLOBEvTv Therapeutics Announces 2023 Second Quarter Financial..
2023/8/1021:33PRNUSCantex Pharmaceuticals Announces Article Published in npj..
2023/7/2105:22EDGAR2Form 8-K - Current report

最近閲覧した銘柄

Delayed Upgrade Clock